Navigation Links
New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
Date:9/19/2007

PARSIPPANY, N.J., Sept. 19 /PRNewswire/ -- Over 20 new speakers will grace the faculty of the "Pharma & Biotech Competitive Intelligence & Business Analysis" conference in two weeks in New Jersey. The conference is the gold standard for pharmaceutical CI, Business Analysis, and Market Forecasting executives; 200 from the top 25 companies will gather on October 1-2 to attend the meeting. Competition has never been fiercer to launch successful products and monitor competitor moves in crowded therapeutic classes. This year's show brings together an unprecedented gathering of speakers and attendees from around the industry.

Among the many new speakers the audience will have opportunity to hear from are:

-- Bill Sammon

Senior Director of Strategy Information Analysis

Pfizer

-- David Stefanoni

Director, Business Intelligence; Business Excellent, Analytics &

Planning

Sanofi-Aventis

-- David Kamenir

Associate Director, Strategic Brand & Competitor Insights

Novo Nordisk

-- Ian Malcolm

Vice President Strategic Marketing

Exelixis

-- Susanne Laningham

Director Business Analysis & Information

Amgen

-- Thomas Han

Director, Strategic Marketing

Biovail

-- J J Owen

Associate Director, Scientific & Competitor Analysis

Millennium

-- Joshua Owolabi

Assistant Director, Discovery & Assessment Group

TAP Pharmaceuticals

-- Renee Pierson

Director

Ortho McNeil Pharmaceutical

The conference and exhibition will take place in Parsippany, NJ and is the only annual conference featuring 90% pharmaceutical company speakers for just the life sciences industry, reports Mark Alexay of Apaporis, the organizer. 35 pharmaceutical company speakers are featured this year; the attendee list is posted at http://www.pharmabiotechci.com.

The speaking faculty includes a pharmaceutical industry "Who's Who" list of CI professionals from top companies including Alcon Laboratories, Amgen, Aspreva, Bayer HealthCare, Bayer Schering Pharma, Biovail, Boehringer Ingelheim, Centocor, Cyberonics, Cyclacel, Daiichi Medical Research, Eisai, Exelixis, Genentech, Genzyme, Merck, Millennium, Novo Nordisk, Onconova Therapeutics, Organon International, Ortho McNeil Pharmaceutical, Pfizer, Sanofi-Aventis, Shire Laboratories, Supernus Pharmaceuticals, TAP, Wyeth, ZymoGenetics.

Contact the organizers for information or about the exhibition -- Amy Yueh at ayueh@pharmabiotechci.com / 212.228.7974 or Mark Alexay at 201.452.4023.


'/>"/>
SOURCE Apaporis
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. In competitive biotech world, Wisconsin cant afford to fall behind
2. Modernizing the tax code can make Wisconsin tech businesses more competitive
3. Is Googles cafeteria a competitive weapon?
4. Wisconsin can shine in the competitive biotech world, even among the giants
5. Wisconsin must produce more science-savvy students to remain competitive
6. Is your competitive edge really a wedge?
7. Schneider Logistics Helps Manufacturers Secure Competitive Advantage
8. Looking to be Competitive? Try Speed Networking
9. Meat-snack maker selects Prescient Applied Intelligence tech package
10. Are you gathering information or intelligence about competitors?
11. Business Intelligence and Process Effectiveness Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... ... Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH ... Drug Evaluation Staff has joined the company as an Expert Consultant. , In ...
(Date:2/22/2017)... and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ ... today announced its financial results for the fourth ... "Our annual 2016 financial results reflect continued growth ... exceeded $700 million," said Martine Rothblatt, Ph.D., United ... results strengthen our ability to develop and advance ...
(Date:2/21/2017)... ... February 21, 2017 , ... During HIMSS ... digital health applications, announced a partnership with Redox, a leader in cloud-based healthcare ... many clinical systems while keeping data secure in the cloud. , The digital ...
(Date:2/21/2017)... ... February 21, 2017 , ... Cancer diagnostics ... has joined its executive team to lead the development and commercialization of its ... help improve the diagnosis and treatment of cancer. The CIDT addresses the need ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/23/2017)... -- The latest mobile market research from Acuity Market Intelligence ... quarterly average price of a biometric smartphone decreased from ... There are now 120 sub-$150 models on the market ... 28 a year ago at an average price of ... , Acuity Market Intelligence Principal, "Biometric Smartphones are a ...
(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
Breaking Biology News(10 mins):